Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Retro Biosciences, supported by Sam Altman, is raising $1 billion to create drugs aimed at extending human lifespan by 10 years.
MAIN POINTS
- Retro Biosciences is backed by Sam Altman.
- The company is focused on developing drugs.
- Their goal is to extend human lifespan by 10 years.
- They are raising $1 billion for this initiative.
TAKEAWAYS
- The significant financial backing highlights the potential impact of lifespan-extending drugs.
- Sam Altman's involvement suggests strong confidence in the project's success.
- Extending lifespan by a decade could revolutionize healthcare and aging.
- The ambitious funding goal reflects the scale and ambition of the project.